Annexon, Inc. (ANNX)
NASDAQ: ANNX · Real-Time Price · USD
4.190
-0.020 (-0.48%)
At close: Nov 11, 2026, 4:00 PM EST
4.220
+0.030 (0.72%)
Pre-market: Nov 12, 2026, 7:00 AM EST
Annexon Market Cap
Annexon has a market cap or net worth of $799.3 million as of November 11, 2026. It is the 11,434th most valuable company in the world and the 2,396th biggest in the United States. Its market cap has increased by 124.20% in one year.
Market Cap
799.30M
Enterprise Value
659.12M
1-Year Change
124.20%
Global Rank
Country Rank
#2,396 United States
Category
ChartMarket Cap Chart
Since July 24, 2020, Annexon's market cap has increased from $639.51M to $799.30M, an increase of 24.99%. That is a compound annual growth rate of 3.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 799.30M | 6.82% |
| Dec 31, 2025 | 748.26M | 36.84% |
| Dec 31, 2024 | 546.82M | 53.75% |
| Dec 29, 2023 | 355.65M | 44.43% |
| Dec 30, 2022 | 246.25M | -44.15% |
| Dec 31, 2021 | 440.93M | -53.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immatics | 876.18M |
| Bambusa Therapeutics | 868.57M |
| Syndax Pharmaceuticals | 854.37M |
| Obsidian Therapeutics | 851.85M |
| Alumis | 827.09M |
| Rigel Pharmaceuticals | 823.25M |
| Lexicon Pharmaceuticals | 821.46M |
| Ginkgo Bioworks Holdings | 808.08M |